Ribonuclease Inhibitor Regulates Neovascularization by Human Angiogenin

详细信息    查看全文

• 作者：Kimberly A. Dickson ; Dong-Ku Kang ; Young Sam Kwon ; Jae Chan Kim ; Peter A. Leland ; Byung-Moon Kim ; Soo-Ik Chang ; Ronald T. Raines
• 刊名：Biochemistry
• 出版年：2009
• 出版时间：May 12, 2009
• 年：2009
• 卷：48
• 期：18
• 页码：3804-3806
• 全文大小：801K
• 年卷期：v.48,no.18(May 12, 2009)
• ISSN：1520-4995

文摘

Human angiogenin (ANG) is a homologue of bovine pancreatic ribonuclease (RNase A) that induces neovascularization. ANG is the only human angiogenic factor that possesses ribonucleolytic activity. To stimulate blood vessel growth, ANG must be transported to the nucleus and must retain its catalytic activity. Like other mammalian homologues of RNase A, ANG forms a femtomolar complex with the cytosolic ribonuclease inhibitor protein (RI). To determine whether RI affects ANG-induced angiogenesis, we created G85R/G86R ANG, which possesses 10⁶-fold lower affinity for RI but retains wild-type ribonucleolytic activity. The neovascularization of rabbit corneas by G85R/G86R ANG was more pronounced and more rapid than by wild-type ANG. These findings provide the first direct evidence that RI serves to regulate the biological activity of ANG in vivo.